Global Platinum-based Anticancer APIs Market Research Report 2022 - Market Study Report

Global Platinum-based Anticancer APIs Market Research Report 2022

Report Format: PDF   |   Report ID: 5515231   |   Published Date: August 2022   |   Pages:  105  

Choose License
Market Analysis and Insights: Global Platinum-based Anticancer APIs Market
Due to the COVID-19 pandemic, the global Platinum-based Anticancer APIs market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Cisplatin accounting for  % of the Platinum-based Anticancer APIs global market in 2021, is projected to value US$  million by 2028, growing at a revised  % CAGR from 2022 to 2028. While Testicular Cancer segment is altered to an  % CAGR throughout this forecast period.
North America Platinum-based Anticancer APIs market is estimated at US$  million in 2021, while Europe is forecast to reach US$  million by 2028. The proportion of the North America is % in 2021, while Europe percentage is %, and it is predicted that Europe share will reach % in 2028, trailing a CAGR of  % through the analysis period 2022-2028. As for the Asia, the notable markets are Japan and South Korea, CAGR is  % and  % respectively for the next 6-year period.
The global major manufacturers of Platinum-based Anticancer APIs include Jiangsu Hengrui Medicine, Nanjing Pharmaceutical Factory, Qilu Pharmaceutical, Neptunus, Hisun, Jiangsu HaiCi biological pharmaceutical, Kunming Guiyan Pharmaceutical, Lingnan Pharmacy and Jinzhou Jiutai Pharmaceutical, etc. In terms of revenue, the global 3 largest players have a  % market share of Platinum-based Anticancer APIs in 2021.
Global Platinum-based Anticancer APIs Market: Drivers and Restrains
The research report has incorporated the analysis of different factors that augment the market's growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2017 to 2028. This section mentions the volume of production by region from 2017 to 2028. Pricing analysis is included in the report according to each type from the year 2017 to 2028, manufacturer from 2017 to 2022, region from 2017 to 2022, and global price from 2017 to 2028.
A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert's opinions have been taken to understand the market better.
Global Platinum-based Anticancer APIs Market: Segment Analysis
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2017 to 2028. by Application segment also provides consumption during the forecast period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
    Cisplatin
    Carboplatin
    Oxaliplatin
    Nedaplatin
    Others
Segment by Application
    Testicular Cancer
    Osteosarcoma
    Breast Cancer
    Esophageal Cancer
    NSCLC
    Other
By Company
    Jiangsu Hengrui Medicine
    Nanjing Pharmaceutical Factory
    Qilu Pharmaceutical
    Neptunus
    Hisun
    Jiangsu HaiCi biological pharmaceutical
    Kunming Guiyan Pharmaceutical
    Lingnan Pharmacy
    Jinzhou Jiutai Pharmaceutical
    Nanjing Hairun Pharmaceutical
    Simcere
    Teva
    Cipla
    Heraeus
    Hospira(Pfizer)
    Taj Pharmaceuticals
    Umicore Precious Metals Chemistry
Production by Region
    North America
    Europe
    China
    India
Consumption by Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
1 Platinum-based Anticancer APIs Market Overview
    1.1 Product Overview and Scope of Platinum-based Anticancer APIs
    1.2 Platinum-based Anticancer APIs Segment by Type
        1.2.1 Global Platinum-based Anticancer APIs Market Size Growth Rate Analysis by Type 2022 VS 2028
        1.2.2 Cisplatin
        1.2.3 Carboplatin
        1.2.4 Oxaliplatin
        1.2.5 Nedaplatin
        1.2.6 Others
    1.3 Platinum-based Anticancer APIs Segment by Application
        1.3.1 Global Platinum-based Anticancer APIs Consumption Comparison by Application: 2022 VS 2028
        1.3.2 Testicular Cancer
        1.3.3 Osteosarcoma
        1.3.4 Breast Cancer
        1.3.5 Esophageal Cancer
        1.3.6 NSCLC
        1.3.7 Other
    1.4 Global Market Growth Prospects
        1.4.1 Global Platinum-based Anticancer APIs Revenue Estimates and Forecasts (2017-2028)
        1.4.2 Global Platinum-based Anticancer APIs Production Capacity Estimates and Forecasts (2017-2028)
        1.4.3 Global Platinum-based Anticancer APIs Production Estimates and Forecasts (2017-2028)
    1.5 Global Market Size by Region
        1.5.1 Global Platinum-based Anticancer APIs Market Size Estimates and Forecasts by Region: 2017 VS 2021 VS 2028
        1.5.2 North America Platinum-based Anticancer APIs Estimates and Forecasts (2017-2028)
        1.5.3 Europe Platinum-based Anticancer APIs Estimates and Forecasts (2017-2028)
        1.5.4 China Platinum-based Anticancer APIs Estimates and Forecasts (2017-2028)
        1.5.5 India Platinum-based Anticancer APIs Estimates and Forecasts (2017-2028)
2 Market Competition by Manufacturers
    2.1 Global Platinum-based Anticancer APIs Production Capacity Market Share by Manufacturers (2017-2022)
    2.2 Global Platinum-based Anticancer APIs Revenue Market Share by Manufacturers (2017-2022)
    2.3 Platinum-based Anticancer APIs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.4 Global Platinum-based Anticancer APIs Average Price by Manufacturers (2017-2022)
    2.5 Manufacturers Platinum-based Anticancer APIs Production Sites, Area Served, Product Types
    2.6 Platinum-based Anticancer APIs Market Competitive Situation and Trends
        2.6.1 Platinum-based Anticancer APIs Market Concentration Rate
        2.6.2 Global 5 and 10 Largest Platinum-based Anticancer APIs Players Market Share by Revenue
        2.6.3 Mergers & Acquisitions, Expansion
3 Production Capacity by Region
    3.1 Global Production Capacity of Platinum-based Anticancer APIs Market Share by Region (2017-2022)
    3.2 Global Platinum-based Anticancer APIs Revenue Market Share by Region (2017-2022)
    3.3 Global Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
    3.4 North America Platinum-based Anticancer APIs Production
        3.4.1 North America Platinum-based Anticancer APIs Production Growth Rate (2017-2022)
        3.4.2 North America Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
    3.5 Europe Platinum-based Anticancer APIs Production
        3.5.1 Europe Platinum-based Anticancer APIs Production Growth Rate (2017-2022)
        3.5.2 Europe Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
    3.6 China Platinum-based Anticancer APIs Production
        3.6.1 China Platinum-based Anticancer APIs Production Growth Rate (2017-2022)
        3.6.2 China Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
    3.7 India Platinum-based Anticancer APIs Production
        3.7.1 India Platinum-based Anticancer APIs Production Growth Rate (2017-2022)
        3.7.2 India Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
4 Global Platinum-based Anticancer APIs Consumption by Region
    4.1 Global Platinum-based Anticancer APIs Consumption by Region
        4.1.1 Global Platinum-based Anticancer APIs Consumption by Region
        4.1.2 Global Platinum-based Anticancer APIs Consumption Market Share by Region
    4.2 North America
        4.2.1 North America Platinum-based Anticancer APIs Consumption by Country
        4.2.2 United States
        4.2.3 Canada
    4.3 Europe
        4.3.1 Europe Platinum-based Anticancer APIs Consumption by Country
        4.3.2 Germany
        4.3.3 France
        4.3.4 U.K.
        4.3.5 Italy
        4.3.6 Russia
    4.4 Asia Pacific
        4.4.1 Asia Pacific Platinum-based Anticancer APIs Consumption by Region
        4.4.2 China
        4.4.3 Japan
        4.4.4 South Korea
        4.4.5 China Taiwan
        4.4.6 Southeast Asia
        4.4.7 India
        4.4.8 Australia
    4.5 Latin America
        4.5.1 Latin America Platinum-based Anticancer APIs Consumption by Country
        4.5.2 Mexico
        4.5.3 Brazil
5 Segment by Type
    5.1 Global Platinum-based Anticancer APIs Production Market Share by Type (2017-2022)
    5.2 Global Platinum-based Anticancer APIs Revenue Market Share by Type (2017-2022)
    5.3 Global Platinum-based Anticancer APIs Price by Type (2017-2022)
6 Segment by Application
    6.1 Global Platinum-based Anticancer APIs Production Market Share by Application (2017-2022)
    6.2 Global Platinum-based Anticancer APIs Revenue Market Share by Application (2017-2022)
    6.3 Global Platinum-based Anticancer APIs Price by Application (2017-2022)
7 Key Companies Profiled
    7.1 Jiangsu Hengrui Medicine
        7.1.1 Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Corporation Information
        7.1.2 Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Product Portfolio
        7.1.3 Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.1.4 Jiangsu Hengrui Medicine Main Business and Markets Served
        7.1.5 Jiangsu Hengrui Medicine Recent Developments/Updates
    7.2 Nanjing Pharmaceutical Factory
        7.2.1 Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Corporation Information
        7.2.2 Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Product Portfolio
        7.2.3 Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.2.4 Nanjing Pharmaceutical Factory Main Business and Markets Served
        7.2.5 Nanjing Pharmaceutical Factory Recent Developments/Updates
    7.3 Qilu Pharmaceutical
        7.3.1 Qilu Pharmaceutical Platinum-based Anticancer APIs Corporation Information
        7.3.2 Qilu Pharmaceutical Platinum-based Anticancer APIs Product Portfolio
        7.3.3 Qilu Pharmaceutical Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.3.4 Qilu Pharmaceutical Main Business and Markets Served
        7.3.5 Qilu Pharmaceutical Recent Developments/Updates
    7.4 Neptunus
        7.4.1 Neptunus Platinum-based Anticancer APIs Corporation Information
        7.4.2 Neptunus Platinum-based Anticancer APIs Product Portfolio
        7.4.3 Neptunus Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.4.4 Neptunus Main Business and Markets Served
        7.4.5 Neptunus Recent Developments/Updates
    7.5 Hisun
        7.5.1 Hisun Platinum-based Anticancer APIs Corporation Information
        7.5.2 Hisun Platinum-based Anticancer APIs Product Portfolio
        7.5.3 Hisun Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.5.4 Hisun Main Business and Markets Served
        7.5.5 Hisun Recent Developments/Updates
    7.6 Jiangsu HaiCi biological pharmaceutical
        7.6.1 Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Corporation Information
        7.6.2 Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Product Portfolio
        7.6.3 Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.6.4 Jiangsu HaiCi biological pharmaceutical Main Business and Markets Served
        7.6.5 Jiangsu HaiCi biological pharmaceutical Recent Developments/Updates
    7.7 Kunming Guiyan Pharmaceutical
        7.7.1 Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Corporation Information
        7.7.2 Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Product Portfolio
        7.7.3 Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.7.4 Kunming Guiyan Pharmaceutical Main Business and Markets Served
        7.7.5 Kunming Guiyan Pharmaceutical Recent Developments/Updates
    7.8 Lingnan Pharmacy
        7.8.1 Lingnan Pharmacy Platinum-based Anticancer APIs Corporation Information
        7.8.2 Lingnan Pharmacy Platinum-based Anticancer APIs Product Portfolio
        7.8.3 Lingnan Pharmacy Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.8.4 Lingnan Pharmacy Main Business and Markets Served
        7.7.5 Lingnan Pharmacy Recent Developments/Updates
    7.9 Jinzhou Jiutai Pharmaceutical
        7.9.1 Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Corporation Information
        7.9.2 Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Product Portfolio
        7.9.3 Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.9.4 Jinzhou Jiutai Pharmaceutical Main Business and Markets Served
        7.9.5 Jinzhou Jiutai Pharmaceutical Recent Developments/Updates
    7.10 Nanjing Hairun Pharmaceutical
        7.10.1 Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Corporation Information
        7.10.2 Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Product Portfolio
        7.10.3 Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.10.4 Nanjing Hairun Pharmaceutical Main Business and Markets Served
        7.10.5 Nanjing Hairun Pharmaceutical Recent Developments/Updates
    7.11 Simcere
        7.11.1 Simcere Platinum-based Anticancer APIs Corporation Information
        7.11.2 Simcere Platinum-based Anticancer APIs Product Portfolio
        7.11.3 Simcere Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.11.4 Simcere Main Business and Markets Served
        7.11.5 Simcere Recent Developments/Updates
    7.12 Teva
        7.12.1 Teva Platinum-based Anticancer APIs Corporation Information
        7.12.2 Teva Platinum-based Anticancer APIs Product Portfolio
        7.12.3 Teva Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.12.4 Teva Main Business and Markets Served
        7.12.5 Teva Recent Developments/Updates
    7.13 Cipla
        7.13.1 Cipla Platinum-based Anticancer APIs Corporation Information
        7.13.2 Cipla Platinum-based Anticancer APIs Product Portfolio
        7.13.3 Cipla Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.13.4 Cipla Main Business and Markets Served
        7.13.5 Cipla Recent Developments/Updates
    7.14 Heraeus
        7.14.1 Heraeus Platinum-based Anticancer APIs Corporation Information
        7.14.2 Heraeus Platinum-based Anticancer APIs Product Portfolio
        7.14.3 Heraeus Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.14.4 Heraeus Main Business and Markets Served
        7.14.5 Heraeus Recent Developments/Updates
    7.15 Hospira(Pfizer)
        7.15.1 Hospira(Pfizer) Platinum-based Anticancer APIs Corporation Information
        7.15.2 Hospira(Pfizer) Platinum-based Anticancer APIs Product Portfolio
        7.15.3 Hospira(Pfizer) Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.15.4 Hospira(Pfizer) Main Business and Markets Served
        7.15.5 Hospira(Pfizer) Recent Developments/Updates
    7.16 Taj Pharmaceuticals
        7.16.1 Taj Pharmaceuticals Platinum-based Anticancer APIs Corporation Information
        7.16.2 Taj Pharmaceuticals Platinum-based Anticancer APIs Product Portfolio
        7.16.3 Taj Pharmaceuticals Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.16.4 Taj Pharmaceuticals Main Business and Markets Served
        7.16.5 Taj Pharmaceuticals Recent Developments/Updates
    7.17 Umicore Precious Metals Chemistry
        7.17.1 Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Corporation Information
        7.17.2 Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Product Portfolio
        7.17.3 Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
        7.17.4 Umicore Precious Metals Chemistry Main Business and Markets Served
        7.17.5 Umicore Precious Metals Chemistry Recent Developments/Updates
8 Platinum-based Anticancer APIs Manufacturing Cost Analysis
    8.1 Platinum-based Anticancer APIs Key Raw Materials Analysis
        8.1.1 Key Raw Materials
        8.1.2 Key Suppliers of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
    8.3 Manufacturing Process Analysis of Platinum-based Anticancer APIs
    8.4 Platinum-based Anticancer APIs Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
    9.1 Marketing Channel
    9.2 Platinum-based Anticancer APIs Distributors List
    9.3 Platinum-based Anticancer APIs Customers
10 Market Dynamics
    10.1 Platinum-based Anticancer APIs Industry Trends
    10.2 Platinum-based Anticancer APIs Market Drivers
    10.3 Platinum-based Anticancer APIs Market Challenges
    10.4 Platinum-based Anticancer APIs Market Restraints
11 Production and Supply Forecast
    11.1 Global Forecasted Production of Platinum-based Anticancer APIs by Region (2023-2028)
    11.2 North America Platinum-based Anticancer APIs Production, Revenue Forecast (2023-2028)
    11.3 Europe Platinum-based Anticancer APIs Production, Revenue Forecast (2023-2028)
    11.4 China Platinum-based Anticancer APIs Production, Revenue Forecast (2023-2028)
    11.5 India Platinum-based Anticancer APIs Production, Revenue Forecast (2023-2028)
12 Consumption and Demand Forecast
    12.1 Global Forecasted Demand Analysis of Platinum-based Anticancer APIs
    12.2 North America Forecasted Consumption of Platinum-based Anticancer APIs by Country
    12.3 Europe Market Forecasted Consumption of Platinum-based Anticancer APIs by Country
    12.4 Asia Pacific Market Forecasted Consumption of Platinum-based Anticancer APIs by Region
    12.5 Latin America Forecasted Consumption of Platinum-based Anticancer APIs by Country
13 Forecast by Type and by Application (2023-2028)
    13.1 Global Production, Revenue and Price Forecast by Type (2023-2028)
        13.1.1 Global Forecasted Production of Platinum-based Anticancer APIs by Type (2023-2028)
        13.1.2 Global Forecasted Revenue of Platinum-based Anticancer APIs by Type (2023-2028)
        13.1.3 Global Forecasted Price of Platinum-based Anticancer APIs by Type (2023-2028)
    13.2 Global Forecasted Consumption of Platinum-based Anticancer APIs by Application (2023-2028)
        13.2.1 Global Forecasted Production of Platinum-based Anticancer APIs by Application (2023-2028)
        13.2.2 Global Forecasted Revenue of Platinum-based Anticancer APIs by Application (2023-2028)
        13.2.3 Global Forecasted Price of Platinum-based Anticancer APIs by Application (2023-2028)
14 Research Finding and Conclusion
15 Methodology and Data Source
    15.1 Methodology/Research Approach
        15.1.1 Research Programs/Design
        15.1.2 Market Size Estimation
        15.1.3 Market Breakdown and Data Triangulation
    15.2 Data Source
        15.2.1 Secondary Sources
        15.2.2 Primary Sources
    15.3 Author List
    15.4 Disclaimer

List of Tables Table 1. Global Platinum-based Anticancer APIs Market Size by Type (Kiloton) & (US$ Million) (2022 VS 2028) Table 2. Global Platinum-based Anticancer APIs Market Size by Application (Kiloton) & (US$ Million) (2022 VS 2028) Table 3. Platinum-based Anticancer APIs Market Size Comparison by Region: 2017 VS 2021 VS 2028 Table 4. Global Platinum-based Anticancer APIs Production Capacity by Manufacturers (2017-2022) & (Kiloton) Table 5. Global Platinum-based Anticancer APIs Production (Kiloton) by Manufacturers (2017-2022) Table 6. Global Platinum-based Anticancer APIs Production Market Share by Manufacturers (2017-2022) Table 7. Global Platinum-based Anticancer APIs Revenue by Manufacturers (2017-2022) & (US$ Million) Table 8. Global Platinum-based Anticancer APIs Revenue Share by Manufacturers (2017-2022) Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Platinum-based Anticancer APIs as of 2021) Table 10. Global Market Platinum-based Anticancer APIs Average Price (US$/Ton) of Key Manufacturers (2017-2022) Table 11. Manufacturers Platinum-based Anticancer APIs Production Sites and Area Served Table 12. Manufacturers Platinum-based Anticancer APIs Product Types Table 13. Global Platinum-based Anticancer APIs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Mergers & Acquisitions, Expansion Table 15. Global Platinum-based Anticancer APIs Production Capacity (Kiloton) by Region (2017-2022) Table 16. Global Platinum-based Anticancer APIs Production (Kiloton) by Region (2017-2022) Table 17. Global Platinum-based Anticancer APIs Revenue (US$ Million) by Region (2017-2022) Table 18. Global Platinum-based Anticancer APIs Revenue Market Share by Region (2017-2022) Table 19. Global Platinum-based Anticancer APIs Production Capacity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 20. North America Platinum-based Anticancer APIs Production Capacity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 21. Europe Platinum-based Anticancer APIs Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 22. China Platinum-based Anticancer APIs Production Capacity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 23. India Platinum-based Anticancer APIs Production Capacity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 24. Global Platinum-based Anticancer APIs Consumption Market by Region (2017-2022) & (Kiloton) Table 25. Global Platinum-based Anticancer APIs Consumption Market Share by Region (2017-2022) Table 26. North America Platinum-based Anticancer APIs Consumption by Country (2017-2022) & (Kiloton) Table 27. Europe Platinum-based Anticancer APIs Consumption by Country (2017-2022) & (Kiloton) Table 28. Asia Pacific Platinum-based Anticancer APIs Consumption by Region (2017-2022) & (Kiloton) Table 29. Latin America Platinum-based Anticancer APIs Consumption by Country (2017-2022) & (Kiloton) Table 30. Global Platinum-based Anticancer APIs Production (Kiloton) by Type (2017-2022) Table 31. Global Platinum-based Anticancer APIs Production Market Share by Type (2017-2022) Table 32. Global Platinum-based Anticancer APIs Revenue (US$ Million) by Type (2017-2022) Table 33. Global Platinum-based Anticancer APIs Revenue Share by Type (2017-2022) Table 34. Global Platinum-based Anticancer APIs Price (US$/Ton) by Type (2017-2022) Table 35. Global Platinum-based Anticancer APIs Production by Application (2017-2022) & (Kiloton) Table 36. Global Platinum-based Anticancer APIs Production Market Share by Application (2017-2022) Table 37. Global Platinum-based Anticancer APIs Revenue (US$ Million) by Application (2017-2022) Table 38. Global Platinum-based Anticancer APIs Revenue Share by Application (2017-2022) Table 39. Global Platinum-based Anticancer APIs Price (US$/Ton) by Application (2017-2022) Table 40. Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Corporation Information Table 41. Jiangsu Hengrui Medicine Specification and Application Table 42. Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Production Capacity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 43. Jiangsu Hengrui Medicine Main Business and Markets Served Table 44. Jiangsu Hengrui Medicine Recent Developments/Updates Table 45. Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Corporation Information Table 46. Nanjing Pharmaceutical Factory Specification and Application Table 47. Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Production Capacity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 48. Nanjing Pharmaceutical Factory Main Business and Markets Served Table 49. Nanjing Pharmaceutical Factory Recent Developments/Updates Table 50. Qilu Pharmaceutical Platinum-based Anticancer APIs Corporation Information Table 51. Qilu Pharmaceutical Specification and Application Table 52. Qilu Pharmaceutical Platinum-based Anticancer APIs Production Capacity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 53. Qilu Pharmaceutical Main Business and Markets Served Table 54. Qilu Pharmaceutical Recent Developments/Updates Table 55. Neptunus Platinum-based Anticancer APIs Corporation Information Table 56. Neptunus Specification and Application Table 57. Neptunus Platinum-based Anticancer APIs Production Capacity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 58. Neptunus Main Business and Markets Served Table 59. Neptunus Recent Developments/Updates Table 60. Hisun Platinum-based Anticancer APIs Corporation Information Table 61. Hisun Specification and Application Table 62. Hisun Platinum-based Anticancer APIs Production Capacity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 63. Hisun Main Business and Markets Served Table 64. Hisun Recent Developments/Updates Table 65. Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Corporation Information Table 66. Jiangsu HaiCi biological pharmaceutical Specification and Application Table 67. Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Production Capacity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 68. Jiangsu HaiCi biological pharmaceutical Main Business and Markets Served Table 69. Jiangsu HaiCi biological pharmaceutical Recent Developments/Updates Table 70. Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Corporation Information Table 71. Kunming Guiyan Pharmaceutical Specification and Application Table 72. Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Production Capacity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 73. Kunming Guiyan Pharmaceutical Main Business and Markets Served Table 74. Kunming Guiyan Pharmaceutical Recent Developments/Updates Table 75. Lingnan Pharmacy Platinum-based Anticancer APIs Corporation Information Table 76. Lingnan Pharmacy Specification and Application Table 77. Lingnan Pharmacy Platinum-based Anticancer APIs Production Capacity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 78. Lingnan Pharmacy Main Business and Markets Served Table 79. Lingnan Pharmacy Recent Developments/Updates Table 80. Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Corporation Information Table 81. Jinzhou Jiutai Pharmaceutical Specification and Application Table 82. Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Production Capacity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 83. Jinzhou Jiutai Pharmaceutical Main Business and Markets Served Table 84. Jinzhou Jiutai Pharmaceutical Recent Developments/Updates Table 85. Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Corporation Information Table 86. Nanjing Hairun Pharmaceutical Specification and Application Table 87. Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Production Capacity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 88. Nanjing Hairun Pharmaceutical Main Business and Markets Served Table 89. Nanjing Hairun Pharmaceutical Recent Developments/Updates Table 90. Simcere Platinum-based Anticancer APIs Corporation Information Table 91. Simcere Specification and Application Table 92. Simcere Platinum-based Anticancer APIs Production Capacity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 93. Simcere Main Business and Markets Served Table 94. Simcere Recent Developments/Updates Table 95. Teva Platinum-based Anticancer APIs Corporation Information Table 96. Teva Specification and Application Table 97. Teva Platinum-based Anticancer APIs Production Capacity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 98. Teva Main Business and Markets Served Table 99. Teva Recent Developments/Updates Table 100. Cipla Platinum-based Anticancer APIs Corporation Information Table 101. Cipla Specification and Application Table 102. Cipla Platinum-based Anticancer APIs Production Capacity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 103. Cipla Main Business and Markets Served Table 104. Cipla Recent Developments/Updates Table 105. Heraeus Platinum-based Anticancer APIs Corporation Information Table 106. Heraeus Specification and Application Table 107. Heraeus Platinum-based Anticancer APIs Production Capacity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 108. Heraeus Main Business and Markets Served Table 109. Heraeus Recent Developments/Updates Table 110. Heraeus Platinum-based Anticancer APIs Corporation Information Table 111. Hospira(Pfizer) Specification and Application Table 112. Hospira(Pfizer) Platinum-based Anticancer APIs Production Capacity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 113. Hospira(Pfizer) Main Business and Markets Served Table 114. Hospira(Pfizer) Recent Developments/Updates Table 115. Taj Pharmaceuticals Platinum-based Anticancer APIs Corporation Information Table 116. Taj Pharmaceuticals Platinum-based Anticancer APIs Production Capacity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 117. Taj Pharmaceuticals Main Business and Markets Served Table 118. Taj Pharmaceuticals Recent Developments/Updates Table 119. Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Corporation Information Table 120. Umicore Precious Metals Chemistry Specification and Application Table 121. Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Production Capacity (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022) Table 122. Umicore Precious Metals Chemistry Main Business and Markets Served Table 123. Umicore Precious Metals Chemistry Recent Developments/Updates Table 124. Production Base and Market Concentration Rate of Raw Material Table 125. Key Suppliers of Raw Materials Table 126. Platinum-based Anticancer APIs Distributors List Table 127. Platinum-based Anticancer APIs Customers List Table 128. Platinum-based Anticancer APIs Market Trends Table 129. Platinum-based Anticancer APIs Market Drivers Table 130. Platinum-based Anticancer APIs Market Challenges Table 131. Platinum-based Anticancer APIs Market Restraints Table 132. Global Platinum-based Anticancer APIs Production (Kiloton) Forecast by Region (2023-2028) Table 133. North America Platinum-based Anticancer APIs Consumption Forecast by Country (2023-2028) & (Kiloton) Table 134. Europe Platinum-based Anticancer APIs Consumption Forecast by Country (2023-2028) & (Kiloton) Table 135. Asia Pacific Platinum-based Anticancer APIs Consumption Forecast by Region (2023-2028) & (Kiloton) Table 136. Latin America Platinum-based Anticancer APIs Consumption Forecast by Country (2023-2028) & (Kiloton) Table 137. Global Platinum-based Anticancer APIs Production Forecast by Type (2023-2028) & (Kiloton) Table 138. Global Platinum-based Anticancer APIs Revenue Forecast by Type (2023-2028) & (US$ Million) Table 139. Global Platinum-based Anticancer APIs Price Forecast by Type (2023-2028) & (US$/Ton) Table 140. Global Platinum-based Anticancer APIs Production Forecast by Application (2023-2028) & (Kiloton) Table 141. Global Platinum-based Anticancer APIs Revenue Forecast by Application (2023-2028) & (US$ Million) Table 142. Global Platinum-based Anticancer APIs Price Forecast by Application (2023-2028) & (US$/Ton) Table 143. Research Programs/Design for This Report Table 144. Key Data Information from Secondary Sources Table 145. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Platinum-based Anticancer APIs Figure 2. Global Platinum-based Anticancer APIs Market Share by Type: 2022 VS 2028 Figure 3. Cisplatin Product Picture Figure 4. Carboplatin Product Picture Figure 5. Oxaliplatin Product Picture Figure 6. Nedaplatin Product Picture Figure 7. Others Product Picture Figure 8. Global Platinum-based Anticancer APIs Market Share by Application: 2022 VS 2028 Figure 9. Testicular Cancer Figure 10. Osteosarcoma Figure 11. Breast Cancer Figure 12. Esophageal Cancer Figure 13. NSCLC Figure 14. Other Figure 15. Global Platinum-based Anticancer APIs Revenue (US$ Million), 2017 VS 2021 VS 2028 Figure 16. Global Platinum-based Anticancer APIs Revenue (US$ Million) (2017-2028) Figure 17. Global Platinum-based Anticancer APIs Production Capacity (Kiloton) & (2017-2028) Figure 18. Global Platinum-based Anticancer APIs Production (Kiloton) & (2017-2028) Figure 19. North America Platinum-based Anticancer APIs Revenue (US$ Million) and Growth Rate (2017-2028) Figure 20. Europe Platinum-based Anticancer APIs Revenue (US$ Million) and Growth Rate (2017-2028) Figure 21. China Platinum-based Anticancer APIs Revenue (US$ Million) and Growth Rate (2017-2028) Figure 22. India Platinum-based Anticancer APIs Revenue (US$ Million) and Growth Rate (2017-2028) Figure 23. Platinum-based Anticancer APIs Production Share by Manufacturers in 2021 Figure 24. Global Platinum-based Anticancer APIs Revenue Share by Manufacturers in 2021 Figure 25. Platinum-based Anticancer APIs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 26. Global Market Platinum-based Anticancer APIs Average Price (US$/Ton) of Key Manufacturers in 2021 Figure 27. The Global 5 and 10 Largest Players: Market Share by Platinum-based Anticancer APIs Revenue in 2021 Figure 28. Global Platinum-based Anticancer APIs Production Market Share by Region (2017-2022) Figure 29. North America Platinum-based Anticancer APIs Production (Kiloton) Growth Rate (2017-2022) Figure 30. Europe Platinum-based Anticancer APIs Production (Kiloton) Growth Rate (2017-2022) Figure 31. China Platinum-based Anticancer APIs Production (Kiloton) Growth Rate (2017-2022) Figure 32. India Platinum-based Anticancer APIs Production (Kiloton) Growth Rate (2017-2022) Figure 33. Global Platinum-based Anticancer APIs Consumption Market Share by Region (2017-2022) Figure 34. North America Platinum-based Anticancer APIs Consumption and Growth Rate (2017-2022) & (Kiloton) Figure 35. North America Platinum-based Anticancer APIs Consumption Market Share by Country in 2021 Figure 36. Canada Platinum-based Anticancer APIs Consumption Growth Rate (2017-2022) & (Kiloton) Figure 37. U.S. Platinum-based Anticancer APIs Consumption Growth Rate (2017-2022) & (Kiloton) Figure 38. Europe Platinum-based Anticancer APIs Consumption Growth Rate (2017-2022) & (Kiloton) Figure 39. Europe Platinum-based Anticancer APIs Consumption Market Share by Country in 2021 Figure 40. Germany Platinum-based Anticancer APIs Consumption and Growth Rate (2017-2022) & (Kiloton) Figure 41. France Platinum-based Anticancer APIs Consumption and Growth Rate (2017-2022) & (Kiloton) Figure 42. U.K. Platinum-based Anticancer APIs Consumption and Growth Rate (2017-2022) & (Kiloton) Figure 43. Italy Platinum-based Anticancer APIs Consumption and Growth Rate (2017-2022) & (Kiloton) Figure 44. Russia Platinum-based Anticancer APIs Consumption and Growth Rate (2017-2022) & (Kiloton) Figure 45. Asia Pacific Platinum-based Anticancer APIs Consumption and Growth Rate (2017-2022) & (Kiloton) Figure 46. Asia Pacific Platinum-based Anticancer APIs Consumption Market Share by Regions in 2021 Figure 47. China Platinum-based Anticancer APIs Consumption and Growth Rate (2017-2022) & (Kiloton) Figure 48. Japan Platinum-based Anticancer APIs Consumption and Growth Rate (2017-2022) & (Kiloton) Figure 49. South Korea Platinum-based Anticancer APIs Consumption and Growth Rate (2017-2022) & (Kiloton) Figure 50. China Taiwan Platinum-based Anticancer APIs Consumption and Growth Rate (2017-2022) & (Kiloton) Figure 51. Southeast Asia Platinum-based Anticancer APIs Consumption and Growth Rate (2017-2022) & (Kiloton) Figure 52. India Platinum-based Anticancer APIs Consumption and Growth Rate (2017-2022) & (Kiloton) Figure 53. Australia Platinum-based Anticancer APIs Consumption and Growth Rate (2017-2022) & (Kiloton) Figure 54. Latin America Platinum-based Anticancer APIs Consumption and Growth Rate (2017-2022) & (Kiloton) Figure 55. Latin America Platinum-based Anticancer APIs Consumption Market Share by Country in 2021 Figure 56. Mexico Platinum-based Anticancer APIs Consumption and Growth Rate (2017-2022) & (Kiloton) Figure 57. Brazil Platinum-based Anticancer APIs Consumption and Growth Rate (2017-2022) & (Kiloton) Figure 58. Production Market Share of Platinum-based Anticancer APIs by Type (2017-2022) Figure 59. Production Market Share of Platinum-based Anticancer APIs by Type in 2021 Figure 60. Revenue Share of Platinum-based Anticancer APIs by Type (2017-2022) Figure 61. Revenue Market Share of Platinum-based Anticancer APIs by Type in 2021 Figure 62. Production Market Share of Platinum-based Anticancer APIs by Application (2017-2022) Figure 63. Production Market Share of Platinum-based Anticancer APIs by Application in 2021 Figure 64. Revenue Share of Platinum-based Anticancer APIs by Application (2017-2022) Figure 65. Revenue Market Share of Platinum-based Anticancer APIs by Application in 2021 Figure 66. Manufacturing Cost Structure of Platinum-based Anticancer APIs Figure 67. Manufacturing Process Analysis of Platinum-based Anticancer APIs Figure 68. Platinum-based Anticancer APIs Industrial Chain Analysis Figure 69. Channels of Distribution Figure 70. Distributors Profiles Figure 71. Global Platinum-based Anticancer APIs Production Market Share Forecast by Region (2023-2028) Figure 72. North America Platinum-based Anticancer APIs Production (Kiloton) Growth Rate Forecast (2023-2028) Figure 73. Europe Platinum-based Anticancer APIs Production (Kiloton) Growth Rate Forecast (2023-2028) Figure 74. China Platinum-based Anticancer APIs Production (Kiloton) Growth Rate Forecast (2023-2028) Figure 75. India Platinum-based Anticancer APIs Production (Kiloton) Growth Rate Forecast (2023-2028) Figure 76. Global Forecasted Demand Analysis of Platinum-based Anticancer APIs (2017-2028) & (Kiloton) Figure 77. Global Platinum-based Anticancer APIs Production Market Share Forecast by Type (2023-2028) Figure 78. Global Platinum-based Anticancer APIs Revenue Market Share Forecast by Type (2023-2028) Figure 79. Global Platinum-based Anticancer APIs Production Market Share Forecast by Application (2023-2028) Figure 80. Global Platinum-based Anticancer APIs Revenue Market Share Forecast by Application (2023-2028) Figure 81. Bottom-up and Top-down Approaches for This Report Figure 82. Data Triangulation

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research

Can't find what you're looking for about this report?

Submit Query

Go to contact form

Phone Number

1-302-273-0910
Chat with us